Provider review · Updated September 29, 2026
Yale Medicine TRT care responsibilities: from a professional profile to a clinical record
The named practice describes low-testosterone and reproductive care. A biography can establish scope, but it cannot document how an individual finding was interpreted.
Based on public documents · No clinician sign-off or firsthand treatment testing
A practitioner biography answers who describes doing a certain kind of work. A clinical record answers a different question: what happened in a particular assessment, what was concluded and what remains uncertain. Confusing those documents can make an individual care plan appear more complete than it is.
Yale Medicine’s profile for Stanton Honig provides the setting for this responsibility-focused review. We read its clinical statements, the departmental context and relevant medical guidance on September 29, 2026. This is not an evaluation of care received, professional performance or personal suitability for testosterone treatment.
What this article covers
1. Start with the task the profile actually describes
The official biography identifies work in sexual and reproductive medicine and explicitly includes treatment of low testosterone. The Yale urology page locates that work within a broader clinical department. Together, they establish a genuine care role.
They do not document a completed encounter. The Geisinger responsibility review examines another named clinician record with a similar limitation. A profile’s relevance should not be stretched into a statement that an individual’s reports have been reviewed or that a particular explanation has been confirmed. The service can be established while the outcome of the clinical reasoning remains entirely unknown.
2. Separate a professional history from the patient’s history
The Yale profile includes professional appointments, training and publications. Those details concern the practitioner. They do not contain the patient’s symptom history, earlier test context or the reasons another clinician reached a particular conclusion.
MedlinePlus describes laboratory interpretation as combining results with other clinical information. That is why a comprehensive-looking biography cannot stand in for a complete patient record. Our laboratory responsibility guide explains how interpretation differs from obtaining the measurement. Neither the number of publications nor the detail in a staff profile can show that an individual finding has been considered alongside the relevant history and examination.
3. Fertility cooperation does not mean every question is shared
Yale’s biography describes close work with reproductive endocrinologists for fertility patients. This is a specific account of collaboration. It does not show that every testosterone concern enters that same process or that an individual’s future reproductive intentions are already known to the professionals involved.
The Endocrine Society guideline advises against testosterone therapy in men planning fertility in the near term. The implication here is documentary as well as clinical: the goal needs to be explicit in the discussion. A general note about hormone symptoms cannot be assumed to communicate a reproductive priority. If a later clinician sees only a summary about sexual function, the separate fertility question may remain invisible even though the institution describes expertise in both areas. The professionals’ interpretation must connect those issues rather than leave the connection to the patient.
4. A second reader needs the earlier reasoning
An outside assessment may contain both useful evidence and conclusions that need to be reconsidered. The HHS records guidance describes access rights for records held by covered providers and plans, with exceptions; it does not require every organization to share information automatically with another.
The RUSH responsibility review looks at a service that explicitly describes second opinions. Yale’s profile does not publish an equivalent handoff process. Our records-transfer guide explains why preserving the prior clinical explanation matters. Receipt of an old report does not demonstrate acceptance of its conclusion, and a later clinician remains responsible for explaining how it fits the current question.
5. A report can be accessible without being explained
The HHS laboratory-access FAQ distinguishes obtaining a report from requiring its interpretation by the laboratory. Laboratories may direct clinical questions to the ordering or treating professional. That limited federal guidance does not describe Yale’s own result-notification arrangements.
The distinction still helps identify a gap that a practitioner biography cannot fill. A record that says a test occurred may not say what was concluded or which issue remained unresolved. The useful question is who will explain the finding in context. It is not whether a reader can independently match the value to an online threshold or infer a treatment decision from a laboratory flag.
6. Study authorship and medicine identity stay separate
Yale’s profile lists research across several clinical subjects. This review does not treat every publication title as an appraised study, or assume that a named author’s later patient resembles a trial participant. A research list is not an individual medicine record.
The FDA information identifies the preparation used in TRAVERSE and describes subsequent requested labeling changes. Those details illustrate why evidence must stay attached to the actual intervention and document. Our medicine-record guide addresses that identification task. Neither professional authorship nor departmental expertise establishes the contents or instructions of a preparation proposed during a particular assessment.
7. Continuing care needs more than confidence in the profile
The professional guideline includes evaluating response and unwanted effects during care. The July 2026 statement also identifies uncertainty about long-term safety. Those responsibilities are not completed by knowing that a clinician has relevant experience.
Yale’s biography documents a professional practice, while leaving the reader’s own continuing-care arrangement unverified. The meaningful record would preserve the original concern, the interpretation of findings and the person responsible for reassessing them. This is the limit of the public review: it can establish the practice’s stated scope, but it cannot certify the completeness of an explanation or a handoff that has not been observed.
Source documents
Read each document beside the claim it supports. A provider’s offer, a clinical guideline and an exact medicine label are different kinds of evidence.
- Yale Medicine: Stanton Honig, MDOfficial clinical specialist profile · Accessed 2026-09-29
- Yale Medicine: UrologyOfficial system clinical department · Accessed 2026-09-29
- MedlinePlus: How to Understand Your Lab ResultsFederal patient information about interpretation, purposes, methods, units and reference ranges; not a personal interpretation or testing protocol · Accessed 2026-09-29
- Endocrine Society: Testosterone Therapy for Hypogonadism Guideline Resources2018 professional clinical guideline summary, inspected September 29, 2026; dated clinical reference, not a product-specific implemented label · Accessed 2026-09-29
- HHS: Your Medical RecordsFederal records-access guidance for covered providers and plans, with exceptions and the stated Ciox court-order qualification; no automatic sharing requirement · Accessed 2026-09-29
- HHS: Laboratory Report Access and InterpretationFederal Privacy Rule FAQ for covered laboratories; report access does not require interpretation, subject to the stated Ciox qualification · Accessed 2026-09-29
- FDA: Testosterone InformationCurrent regulator overview with June 2026 requested-label-change discussion; dated clinical reference, not a product-specific implemented label · Accessed 2026-09-29
- Endocrine Society: Statement on Testosterone Replacement Therapy, July 16, 2026Current professional policy/clinical statement; dated clinical reference, not a product-specific implemented label · Accessed 2026-09-29